Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells
Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells
复制标题
DOI:
10.1016/j.bbrc.2007.07.033
复制
发表时间:
2007-09-21
影响因子:
3.1
通讯作者:
Chen, Zheng-Wang
中科院分区:
文献类型:
--
作者:
Chen, Xiao-Ping;Liu, Shou;Chen, Zheng-Wang
Different cell line with increased thioredoxin-1 (Trx-1) showed a decreased or increased sensitivity to cell killing by cisplatin. Recently, several studies found that the subcellular localization of Trx-1 is closely associated with its functions. In this study, we explored the association of the nuclear Trx-1 with the cisplatin-mediated apoptosis of breast cancer cells MCF-7. Firstly, we found that higher total Trx-1 accompanied by no change of nuclear Trx-1 can not influence apoptosis induced by cisplatin in MCF-7 cells transferred with Trx-1 cDNA. Secondly, higher nuclear Trx-1 accompanied by no change of total Trx-1 can protect cells from apoptosis induced by cisplatin. Thirdly, high nuclear Trx-1 involves in the cisplatin-resistance in cisplatin-resistive cells. Meanwhile, we found that the mRNA level of p53 is closely correlated with the level of nuclear Trx-1. In summary, we concluded that the nuclear Trx-1 is required to resist apoptosis of MCF-7 cells induced by cisplatin, probably through up-regulating the anti-apoptotic gene, p53. (c) 2007 Published by Elsevier Inc.